Aging
Navigate
Research Paper|Volume 12, Issue 1|pp 894—901

Predicting Fazekas scores from automatic segmentations of white matter signal abnormalities

Nira Cedres1, Daniel Ferreira1, Alejandra Machado1, Sara Shams2,3, Simona Sacuiu4,5,7, Margda Waern4,5,8, Lars-Olof Wahlund1, Anna Zettergren4,5, Silke Kern4,5,7, Ingmar Skoog4,5,7, Eric Westman1,6
  • 1Division of Clinical Geriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet (KI), Stockholm, Sweden
  • 2Department of Clinical Neuroscience, KI, Stockholm, Sweden
  • 3Department of Radiology, Karolinska University Hospital, Stockholm, Sweden
  • 4Centre for Ageing and Health at The University of Gothenburg, Gothenburg, Sweden
  • 5Neuropsychiatric Epidemiology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at The University of Gothenburg, Gothenburg, Sweden
  • 6Department of Neuroimaging, Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
  • 7Region Västra Götaland, Sahlgrenska University Hospital, Department of Neuropsychiatry, Gothenburg, Sweden
  • 8Region Västra Götaland, Sahlgrenska University Hospital, Psychosis Department, Gothenburg, Sweden
* Co-senior authors
Received: September 16, 2019Accepted: December 24, 2019Published: January 12, 2020

Copyright: © 2020 Cedres et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Different measurements of white matter signal abnormalities (WMSA) are often used across studies, which hinders combination of WMSA data from different cohorts. We investigated associations between three commonly used measurements of WMSA, aiming to further understand the association between them and their potential interchangeability: the Fazekas scale, the lesion segmentation tool (LST), and FreeSurfer. We also aimed at proposing cut-off values for estimating low and high Fazekas scale WMSA burden from LST and FreeSurfer WMSA, to facilitate clinical use and interpretation of LST and FreeSurfer WMSA data. A population-based cohort of 709 individuals (all of them 70 years old, 52% female) was investigated. We found a strong association between LST and FreeSurfer WMSA, and an association of Fazekas scores with both LST and FreeSurfer WMSA. The proposed cut-off values were 0.00496 for LST and 0.00321 for FreeSurfer (Total Intracranial volumes (TIV)-corrected values). This study provides data on the association between Fazekas scores, hyperintense WMSA, and hypointense WMSA in a large population-based cohort. The proposed cut-off values for translating LST and FreeSurfer WMSA estimations to low and high Fazekas scale WMSA burden may facilitate the combination of WMSA measurements from different cohorts that used either a FLAIR or a T1-weigthed sequence.